Site icon news.soban.in

Zydus, Formycon sign licensing deal for Keytruda biosimilar in US, Canada (Soban News)

Zydus will commercialise FYB206 in North America, while Formycon will lead development, regulatory filings and supply, with a US FDA filing expected soon​Zydus will commercialise FYB206 in North America, while Formycon will lead development, regulatory filings and supply, with a US FDA filing expected soon ​Latest News [ SOBAN NEWS: International and National ]

Exit mobile version